Breaking News Instant updates and real-time market news.

YELP

Yelp

$35.85

0.16 (0.45%)

, RUTH

Ruth's Hospitality

$25.22

(0.00%)

10:13
04/18/19
04/18
10:13
04/18/19
10:13

Fly Intel: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Yelp (YELP) initiated with an Outperform at BMO Capital. 2. Ruth's Hospitality (RUTH) initiated with an Equal Weight at Stephens. 3. Conmed (CNMD) initiated with a Buy at Stifel. 4. Alcon (ALC) initiated with a Market Perform at BMO Capital. 5. Graham (GHM) initiated with a Buy at Maxim. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

YELP

Yelp

$35.85

0.16 (0.45%)

RUTH

Ruth's Hospitality

$25.22

(0.00%)

CNMD

Conmed

$78.35

(0.00%)

ALC

Alcon

$55.41

-1.27 (-2.24%)

GHM

Graham

$20.03

(0.00%)

  • 24

    Apr

  • 09

    May

  • 18

    May

  • 22

    May

  • 30

    May

  • 13

    Jun

  • 13

    Nov

YELP Yelp
$35.85

0.16 (0.45%)

03/28/19
MSCO
03/28/19
NO CHANGE
MSCO
Local ad survey positive for Google and Facebook, says Morgan Stanley
Morgan Stanley analysts led by Benjamin Swinburne and Brian Nowak said the firm's annual local ad survey showed that expectations to grow marketing budgets remained robust. The survey results were positive for Google parent Alphabet (GOOGL) and Facebook (FB), as Google's search and Instagram stood out as having strong year-over-year increases in the number of small and medium businesses pointing to each as providing "the highest ROI," the analysts noted. Twitter (TWTR) and Yelp (YELP) both fell in terms of usage by local advertisers, the analysts also noted. Outdoor continues to slowly pick up budget share, according to the survey, which makes the analysts incrementally positive on Lamar Advertising (LAMR) and Outfront Media (OUT), they added.
04/05/19
SBSH
04/05/19
NO CHANGE
Target $39
SBSH
Neutral
Citi lowers Yelp estimates below consensus, trims target to $39
Citi analyst Mark May lowered his estimates for Yelp below consensus saying the company's transition in its sales approach and recent introduction of lower-priced ad products creates near-term estimates risk. Further, Yelp's revenue growth could turn negative in Q2, May tells investors in a research note. The analyst lowered his price target for the shares to $39 from $40 and keeps a Neutral rating on Yelp. On the positive, however, the stock's valuation is low and near trough levels, says May. Moreover, recent activism could be a positive catalyst, including a potential acquisition or other operational improvements, the analyst writes.
04/17/19
BMOC
04/17/19
INITIATION
Target $45
BMOC
Outperform
Yelp initiated with an Outperform at BMO Capital
BMO Capital analyst Daniel Salmon initiated Yelp with an Outperform rating and a price target of $45. The analyst says the recent "investor skepticism around changes to Yelp's advertising business and the pull-back in shares provides an attractive entry point." Salmon contends that even though he does not expect the company to reach its FY23 targets, he sees revenue growth accelerating in 2019-2020 and supporting multiple expansion for the stock. The analyst adds that the risk-reward at current levels is skewed positively for Yelp shares.
04/17/19
BMOC
04/17/19
INITIATION
Target $45
BMOC
Outperform
Yelp initiated with an Outperform at BMO Capital
BMO Capital analyst Daniel Salmon initiated Yelp with an Outperform and $45 price target.
RUTH Ruth's Hospitality
$25.22

(0.00%)

08/13/18
RAJA
08/13/18
DOWNGRADE
RAJA
Market Perform
Ruth's Hospitality downgraded to Market Perform at Raymond James
11/14/18
PIPR
11/14/18
NO CHANGE
PIPR
Piper lays out favorite Consumer stocks to own into holiday season
Piper Jaffray analysts led by Erinn Murphy believe the "solid" consumer spending in the first half of the year can continue into the second half with "favorable weather, clean inventories and an extra day between Thanksgiving & Christmas this year serving as catalysts." Ahead of Black Friday, the firm is laying out its favorite Consumer stocks to own into the Holiday. They include G-III Apparel (GIII), Under Armour (UAA), Estee Lauder (EL), PVH Corp. (PVH), Take-Two Interactive (TTWO), Netflix (NFLX), GoDaddy (GDDY) and Ruth's Hospitality (RUTH). Piper analysts are cautious on shares of Stitch Fix (SFIX) and Michaels (MIK).
04/17/19
SPHN
04/17/19
INITIATION
Target $28
SPHN
Equal Weight
Ruth's Hospitality initiated with an Equal Weight at Stephens
Stephens analyst Will Slabaugh started Ruth's Hospitality Group with an Equal Weight rating and $28 price target. The analyst prefers to "wait out the current bout of stock market/interest rate volatility before becoming more constructive." While Ruth's exposure to a potential economic slowdown is "somewhat discounted" in the shares, the historical magnitude of its same-store-sales dip during recessionary times is meaningful enough to warrant a neutral stance, Slabaugh tells investors in a research note.
CNMD Conmed
$78.35

(0.00%)

04/16/19
NEED
04/16/19
NO CHANGE
Target $94
NEED
Buy
Conmed price target raised to $94 from $87 at Needham
Needham analyst Mike Matson raised his price target on Conmed to $94 and kept his Buy rating, saying the company's recently acquired Buffalo Filter business stands to benefit from the trend of rising adoption for surgical smoke evacuation systems by U.S. states and internationally. The analyst cites the latest Colorado law which mitigates for the surgical smoke as a "serious safety hazard" risk.
02/27/19
NEED
02/27/19
NO CHANGE
Target $87
NEED
Buy
Conmed price target raised to $87 from $79 at Needham
Needham analyst Mike Matson raised his price target on on Conmed to $87 and kept his Buy rating, updating his model to include the increased revenue from its acquisition of Buffalo Filter. The analyst contends that his estimates for Buffalo Filter could also prove conservative in light of its limited presence outside the U.S. market, given Conmed's position as an "established international sales organization".
04/17/19
STFL
04/17/19
INITIATION
Target $95
STFL
Buy
Conmed initiated with a Buy at Stifel
Stifel analyst Rick Wise started Conmed with a Buy rating and $95 price target, stating that the company continues to build on its already-improved execution and has multiple initiatives to sustain, and potentially, accelerate top-line growth.
02/19/19
LEHM
02/19/19
UPGRADE
Target $85
LEHM
Overweight
Conmed reinstated with an Overweight from Equal Weight at Barclays
Barclays analyst Kristen Stewart reinstated coverage of Conmed and upgraded the shares to Overweight with an $85 price target. The analyst says the company's recently reported Q4 results, better than expected 2019 guidance, and the completion of the Buffalo Filter transaction ease her concerns around the sustainability of its growth and 2019 expectations. She views Conmed's current valuation as attractive.
ALC Alcon
$55.41

-1.27 (-2.24%)

04/15/19
JEFF
04/15/19
INITIATION
Target $70
JEFF
Buy
Alcon initiated with a Buy at Jefferies
Jefferies analyst Anthony Petrone started Alcon with a Buy rating and $70 price target. The analyst's consumer work points toward a $400M-$600M opportunity for Precision1 while his doctor survey points toward a $200M-$300M opportunity for PanOptix. He sees these and other drivers pushing Alcon's sales growth toward 6%.
04/11/19
SOCG
04/11/19
DOWNGRADE
SOCG
Sell
Societe Generale corrects error in work, downgrades Alcon to Sell
Societe Generale analyst Delphine Le Louet, who initiated Alcon yesterday with a Buy rating and CHF67 price target, said she identified an error in her model and has downgraded the stock to Sell from Buy after correcting her work. Her corrected discounted cash flow valuation analysis leads her to a new price target of CHF44, said the analyst, who apologized for the error and noted she made no changes to her P&L forecasts.
04/18/19
BMOC
04/18/19
INITIATION
Target $54
BMOC
Market Perform
Alcon initiated with a Market Perform at BMO Capital
BMO Capital analyst Joanne Wuensch started Alcon with a Market Perform rating and $54 price target. The analyst, who views the company's end markets as "massive" with favorable demographics, is not a fan of the current valuation and prefers to wait for a better entry point.
04/15/19
04/15/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Pinterest (PINS) initiated with a Neutral at DA Davidson. 2. Five Below (FIVE) initiated with a Buy at BofA/Merrill. 3. Levi Strauss (LEVI) initiated with an Outperform at Telsey Advisory, an Overweight at JPMorgan, a Buy at Citi and Guggenheim, an Equal Weight at Morgan Stanley, and a Neutral at Goldman Sachs and BofA/Merrill. 4. Tocagen (TOCA) initiated with a Market Perform at SVB Leerink. 5. Alcon (ALC) initiated with a Buy at Jefferies, while Allergan (AGN) was initiated with a Hold. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
GHM Graham
$20.03

(0.00%)

04/18/19
MAXM
04/18/19
INITIATION
MAXM
Buy
Graham initiated with a Buy at Maxim
04/18/19
MAXM
04/18/19
INITIATION
Target $27
MAXM
Buy
Graham initiated with a Buy at Maxim
Maxim analyst Tate Sullivan initiated Graham with a Buy rating and a price target of $27, citing the company's "record backlog from U.S. Navy" for aircraft carrier and submarine equipment which should lead to a "meaningful rebound" in earnings. The analyst also believes that Graham may announce a 10% dividend increase in August after its first divident increase in 3 years in 2018 while anticipating the company's "less cyclical than other end markets' " orders from the U.S. Navy to continue to grow.

TODAY'S FREE FLY STORIES

SCHW

Charles Schwab

$51.08

1.48 (2.98%)

, AMTD

TD Ameritrade

$53.47

1.71 (3.30%)

07:46
12/13/19
12/13
07:46
12/13/19
07:46
Upgrade
Charles Schwab, TD Ameritrade, E-Trade rating change  »

Charles Schwab upgraded…

SCHW

Charles Schwab

$51.08

1.48 (2.98%)

AMTD

TD Ameritrade

$53.47

1.71 (3.30%)

ETFC

E-Trade

$46.01

1.08 (2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 26

    Feb

07:45
12/13/19
12/13
07:45
12/13/19
07:45
General news
Treasury Market Outlook: it's rally time in equities »

Treasury Market Outlook:…

HIIQ

Health Insurance Innovations

$19.44

1.09 (5.94%)

, EHTH

eHealth

$93.74

0.89 (0.96%)

07:44
12/13/19
12/13
07:44
12/13/19
07:44
Recommendations
Health Insurance Innovations, eHealth analyst commentary  »

Health Insurance…

HIIQ

Health Insurance Innovations

$19.44

1.09 (5.94%)

EHTH

eHealth

$93.74

0.89 (0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$63.96

1.565 (2.51%)

07:43
12/13/19
12/13
07:43
12/13/19
07:43
Upgrade
Bristol-Myers rating change  »

Bristol-Myers upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FII

Federated Investors

$34.41

0.41 (1.21%)

07:42
12/13/19
12/13
07:42
12/13/19
07:42
Downgrade
Federated Investors rating change  »

JPMorgan downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKX

Skechers

$41.65

0.89 (2.18%)

07:38
12/13/19
12/13
07:38
12/13/19
07:38
Upgrade
Skechers rating change  »

Skechers upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$56.47

0.16 (0.28%)

07:38
12/13/19
12/13
07:38
12/13/19
07:38
Recommendations
Oracle analyst commentary  »

Oracle price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OPI

Office Properties

$32.93

-1.02 (-3.00%)

07:37
12/13/19
12/13
07:37
12/13/19
07:37
Downgrade
Office Properties rating change  »

Morgan Stanley cuts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THTX

Theratechnologies

$3.05

-0.01 (-0.33%)

07:36
12/13/19
12/13
07:36
12/13/19
07:36
Hot Stocks
Theratechnologies reports results from in vitro, in vivo experiments on TH-1902 »

Theratechnologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HWC

Hancock Whitney

$42.61

1.07 (2.58%)

07:35
12/13/19
12/13
07:35
12/13/19
07:35
Upgrade
Hancock Whitney rating change  »

Hancock Whitney upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$11.44

0.46 (4.19%)

, ATVI

Activision Blizzard

$58.60

2.12 (3.75%)

07:35
12/13/19
12/13
07:35
12/13/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

GE

General Electric

$11.44

0.46 (4.19%)

ATVI

Activision Blizzard

$58.60

2.12 (3.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 29

    Jan

NPO

EnPro

$66.48

2.53 (3.96%)

07:34
12/13/19
12/13
07:34
12/13/19
07:34
Conference/Events
EnPro to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$293.92

1.71 (0.59%)

07:33
12/13/19
12/13
07:33
12/13/19
07:33
Hot Stocks
Breaking Hot Stocks news story on Biogen »

Biogen to discontinue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$293.92

1.71 (0.59%)

07:32
12/13/19
12/13
07:32
12/13/19
07:32
Hot Stocks
Biogen: Primary endpoint not statistically significant in Phase 2 PASSPORT study »

Biogen announced topline…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$305.76

2.01 (0.66%)

07:32
12/13/19
12/13
07:32
12/13/19
07:32
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

CG

Carlyle Group

$29.83

-0.36 (-1.19%)

07:31
12/13/19
12/13
07:31
12/13/19
07:31
Hot Stocks
Funds advised by Apax Partners to acquire Coalfire from Carlyle Group, Chertoff »

Funds advised by Apax…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

ADBE

Adobe

$305.76

2.01 (0.66%)

07:30
12/13/19
12/13
07:30
12/13/19
07:30
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

SAFM

Sanderson Farms

$166.66

2.5 (1.52%)

07:30
12/13/19
12/13
07:30
12/13/19
07:30
Initiation
Sanderson Farms initiated  »

Sanderson Farms initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

ORCL

Oracle

$56.47

0.16 (0.28%)

07:30
12/13/19
12/13
07:30
12/13/19
07:30
Recommendations
Oracle analyst commentary  »

Oracle shares to come…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVGO

Broadcom

$327.39

7.53 (2.35%)

07:28
12/13/19
12/13
07:28
12/13/19
07:28
Recommendations
Broadcom analyst commentary  »

Broadcom price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCLH

Norwegian Cruise Line

$56.12

0.72 (1.30%)

07:27
12/13/19
12/13
07:27
12/13/19
07:27
Recommendations
Norwegian Cruise Line analyst commentary  »

Norwegian Cruise Line…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$305.76

2.01 (0.66%)

07:26
12/13/19
12/13
07:26
12/13/19
07:26
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

ADBE

Adobe

$305.76

2.01 (0.66%)

07:25
12/13/19
12/13
07:25
12/13/19
07:25
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

DCP

DCP Midstream

$23.70

-0.56 (-2.31%)

07:25
12/13/19
12/13
07:25
12/13/19
07:25
Initiation
DCP Midstream initiated  »

DCP Midstream initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jan

07:25
12/13/19
12/13
07:25
12/13/19
07:25
Conference/Events
UBS analyst manley to hold an analyst/industry conference call »

Analyst Manley discusses…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.